Edwards Lifesciences Corp (EW)

EW (NYSE:Health Services) EQUITY
$106.34
neg -0.91
-0.85%
Today's Range: 105.96 - 107.33 | EW Avg Daily Volume: 1,988,400
Last Update: 04/29/16 - 11:58 AM EDT
Volume: 416,709
YTD Performance: 35.79%
Open: $107.00
Previous Close: $107.25
52 Week Range: $61.38 - $112.00
Oustanding Shares: 214,597,594
Market Cap: 23,376,115,914
6-Month Chart
TheStreet Ratings Grade for EW
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 11 12 12 12
Moderate Buy 2 2 2 2
Hold 4 3 3 3
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.56 1.44 1.44 1.44
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: 45.58
Price Earnings Comparisons:
EW Sector Avg. S&P 500
45.58 46.50 12.90
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
41.34% 65.13% 234.27%
GROWTH 12 Mo 3 Yr CAGR
Revenue 7.40 0.30 0.09
Net Income -39.00 0.70 0.19
EPS -39.90 0.80 0.21
Earnings for EW:
EBITDA 0.71B
Revenue 2.49B
Average Earnings Estimates
Qtr (06/16) Qtr (09/16) FY (12/16) FY (12/17)
Average Estimate $0.70 $0.64 $2.74 $3.25
Number of Analysts 10 11 11 13
High Estimate $0.72 $0.68 $2.82 $3.46
Low Estimate $0.69 $0.60 $2.69 $2.94
Prior Year $0.56 $0.54 $2.29 $2.74
Growth Rate (Year over Year) 23.54% 19.12% 19.85% 18.44%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands
Utilities, gold, turnarounds and more.
Insurance, waste management, and medical equipment dominate the list.
Traders could buy a breakout to a new high on EW, over $160, and then use a sell-stop below $149.
The upside here looks to be in the $175-$180 area.
Bullish
Oct 19, 2015 | 7:43 AM EDT
EW was placed on the Priority stock list, Wells Fargo said. Transcatheter heart valves should continue to drive growth. 

Columnist Conversations

Biotech is having a very tough day, as investors react to the first miss in 9 quarters from Gilead Sciences (G...
1. Unmasking Zero Hedge 2. Tech as In Wreck (I really think this is a good column , at least I enjoyed writing...
Took a small loss. But sized properly given my risk profile.
Markets turn down in second half of day. As I stated in my column today, lots of high profile misses and a de...

REAL MONEY'S BEST IDEAS

News Breaks

Powered by

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.